Year: 2011
Type: article
Abstract: OBJECTIVE: The study objective was to examine the prevalence of depressive symptoms and relationships to quality of life and demographics in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study's large, ethnically diverse youth with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 704 youth with type 2 diabetes <2 years' duration, aged 10-17 years, and BMI ≥85th percentile completed depressive symptoms and quality of life measures. RESULTS: Some 14.8% reported clinically significant depressive symptoms, and older girls had significantly higher rates than older boys. CONCLUSIONS: Rates of significant depressive symptoms were similar to those of healthy adolescents and lower than those of teens with type 1 diabetes. Elevated depressive symptoms, particularly in older girls, suggest clinicians assess vulnerability.
Source: Diabetes Care
DOI: 10.2337/dc11-0431
Institutions: Baylor College of Medicine, George Washington University, Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver, Children's Hospital of Philadelphia, University of Pennsylvania, Children's Hospital Los Angeles, Yale University, SUNY Upstate Medical University, Saint Louis University, Columbia University Irving Medical Center, University Hospitals Cleveland Medical Center, University of Pittsburgh Medical Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: American Diabetes Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, LifeScan, Massachusetts General Hospital, Yale University, Children's Hospital of Philadelphia, Children's Hospital Los Angeles, University of Oklahoma, Case Western Reserve University, BD, National Institutes of Health, University of Oklahoma Health Sciences Center, University of Colorado Denver, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences, Children's Hospital of Pittsburgh
Awards: General Clinical Research Center, Management of Pediatric Type 2 Diabetes Mellitus, Multi-Center Study of the Treatment of T2DM in Youth, Case Western Reserve University/Cleveland Clinic CTSA (UL1), G2427822680, Southern California Clinical and Translational Science Institute, Harvard Clinical and Translational Science Center (UL1), General Clinical Research Center, G3499161329, University of Pittsburgh Clinical and Translational Science Institute, Type 2 Diabetes in Youth: Beta Cell Preservation, Treatment Alternatives in Pediatric Type 2 Diabetes, TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up, G523627176, Institutional Clinical and Translational Science Award, General Clinical Research Center, G606898507, General Clinical Research Center, General Clinical Research Center, Washington University Institute of Clinical and Translational Sciences (UL1), Yale University Clinical and Translational Science Award Program, General Clinical Research Center, G889535532, G9000042762, G9000238543, GENERAL CLINICAL RESEARCH CENTER, Colorado Clinical and Translational Science Institute (UL1)
OpenAlex ID: W2121924428
